Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.94 USD | -0.47% | +4.44% | +13.77% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 855M |
---|---|---|---|---|---|
Net income 2024 * | -173M | Net income 2025 * | -171M | EV / Sales 2024 * | - |
Net Debt 2024 * | 952K | Net Debt 2025 * | 13.89M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.18
x | P/E ratio 2025 * |
-6
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.14% |
Latest transcript on ALX Oncology Holdings Inc.
1 day | -0.47% | ||
1 week | +4.44% | ||
Current month | -0.47% | ||
1 month | +53.72% | ||
3 months | +12.93% | ||
6 months | +133.98% | ||
Current year | +13.77% |
Managers | Title | Age | Since |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 15-03-31 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 20-03-31 |
Peter García
DFI | Director of Finance/CFO | 62 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 22-11-27 |
Corey Goodman
CHM | Chairman | 72 | 15-02-28 |
Jack Nielsen
BRD | Director/Board Member | 60 | 20-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +5.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 16.94 | -0.47% | 424,667 |
24-04-30 | 17.02 | +0.53% | 527,120 |
24-04-29 | 16.93 | +0.42% | 554,844 |
24-04-26 | 16.86 | -0.06% | 466,719 |
24-04-25 | 16.87 | +4.01% | 509,819 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.77% | 855M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.90% | 22.25B | |
-14.77% | 21.68B | |
-8.96% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- ALXO Stock